{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T11:54:28Z","timestamp":1791028468302,"version":"4.1.0"},"reference-count":39,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Osteoclasts differentiate from hematopoietic precursors under systemic and local controls. Chemokines and receptors direct leukocyte traffic throughout the body and may help regulate site-specific bone resorption. We investigated bone gene expression in vivo during rapid osteoclast differentiation induced by colony-stimulating factor 1 (CSF-1) in Csf1-null toothless (tl\/tl) rats. Long-bone RNA from CSF-1\u2013treated tl\/tl rats was analyzed by high-density microarray over a time course. TRAP (tartrate-resistant acid phosphatase)\u2013positive osteoclasts appeared on day 2, peaked on day 4, and decreased slightly on day 6, as marrow space was expanding. TRAP and cathepsin K mRNA paralleled the cell counts. We examined all chemokine and receptor mRNAs on the arrays. CCL9 was strongly induced and peaked on day 2, as did its receptor, CCR1, and regulatory receptors c-Fms (CSF-1 receptor) and RANK (receptor activator of nuclear factor \u03baB). Other chemokines and receptors showed little or no significant changes. In situ hybridization and immunohistochemistry revealed CCL9 in small, immature osteoclasts on day 2 and in mature cells at later times. Anti-CCL9 antibody inhibited osteoclast differentiation in culture and significantly suppressed the osteoclast response in CSF-1\u2013treated tl\/tl rats. While various chemokines have been implicated in osteoclastogenesis in vitro, this first systematic analysis of chemokines and receptors during osteoclast differentiation in vivo highlights the key role of CCL9 in this process.<\/jats:p>","DOI":"10.1182\/blood-2005-08-3365","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T01:44:43Z","timestamp":1132710283000},"page":"2262-2270","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":78,"title":["Chemokine and chemokine receptor expression during colony stimulating factor-1\u2013induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1\u03b3) in osteoclastogenesis in vivo and in vitro"],"prefix":"10.1182","volume":"107","author":[{"given":"Meiheng","family":"Yang","sequence":"first","affiliation":[{"name":"From the Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevie\u0300ve","family":"Mailhot","sequence":"additional","affiliation":[{"name":"From the Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole A.","family":"MacKay","sequence":"additional","affiliation":[{"name":"From the Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Mason-Savas","sequence":"additional","affiliation":[{"name":"From the Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Aubin","sequence":"additional","affiliation":[{"name":"From the Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Odgren","sequence":"additional","affiliation":[{"name":"From the Department of Cell Biology, University of Massachusetts Medical School, Worcester, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111712274099800_REF1","doi-asserted-by":"crossref","unstructured":"Marks SC, Jr., Odgren PR. The structure and development of the skeleton. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology, Vol. 1 (2nd ed). New York, NY: Academic Press; 2002: 3-15.","DOI":"10.1016\/B978-012098652-1.50103-7"},{"key":"2019111712274099800_REF2","unstructured":"Whyte MP. Sclerosing bone disorders. In: Fauvus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (5th ed). Washington, D.C.: American Society for Bone and Mineral Research; 2003: 449-466."},{"key":"2019111712274099800_REF3","doi-asserted-by":"crossref","unstructured":"de Vernejoul MC, Benichou O. Human osteopetrosis and other sclerosing disorders: recent genetic developments. Calcif Tissue Int. 2001;69: 1-6.","DOI":"10.1007\/s002230020046"},{"key":"2019111712274099800_REF4","doi-asserted-by":"crossref","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423: 337-342.","DOI":"10.1038\/nature01658"},{"key":"2019111712274099800_REF5","doi-asserted-by":"crossref","unstructured":"Moutier R, Toyama K, Cotton WR, Gaines JF. Three recessive genes for congenital osteopetrosis in the Norway rat. J Heredity. 1976;67: 189-190.","DOI":"10.1093\/oxfordjournals.jhered.a108705"},{"key":"2019111712274099800_REF6","doi-asserted-by":"crossref","unstructured":"Marks SC Jr. Osteopetrosis in the toothless (tl) rat: presence of osteoclasts but failure to respond to parathyroid extract or to be cured by infusion of spleen or bone marrow cells from normal littermates. Am J Anat. 1977;149: 289-297.","DOI":"10.1002\/aja.1001490212"},{"key":"2019111712274099800_REF7","doi-asserted-by":"crossref","unstructured":"Dobbins DE, Sood R, Hashiramoto A, Hansen CT, Wilder RL, Remmers EF. Mutation of macrophage colony stimulating factor (Csf1) causes osteopetrosis in the tl rat. Biochem Biophys Res Commun. 2002;294: 1114-1120.","DOI":"10.1016\/S0006-291X(02)00598-3"},{"key":"2019111712274099800_REF8","doi-asserted-by":"crossref","unstructured":"Van Wesenbeeck L, Odgren PR, MacKay CA, et al. The osteopetrotic mutation toothless (tl) is a loss-of-function frameshift mutation in the rat Csf1 gene: evidence of a crucial role for CSF-1 in osteoclastogenesis and endochondral ossification. Proc Natl Acad Sci U S A. 2002;99: 14303-14308.","DOI":"10.1073\/pnas.202332999"},{"key":"2019111712274099800_REF9","doi-asserted-by":"crossref","unstructured":"Sundquist KT, Cecchini MG, Marks SC Jr. Colony-stimulating factor-1 injections improve but do not cure skeletal sclerosis in osteopetrotic (op) mice. Bone. 1995;16: 39-46.","DOI":"10.1016\/8756-3282(95)80009-F"},{"key":"2019111712274099800_","doi-asserted-by":"crossref","unstructured":"Marks SC Jr, Wojtowicz A, Szperl M, et al. Administration of colony stimulating factor-1 corrects some macrophage, dental, and skeletal defects in an osteopetrotic mutation (toothless, tl) in the rat. Bone. 1992;13: 89-93.","DOI":"10.1016\/8756-3282(92)90365-4"},{"key":"2019111712274099800_REF11","doi-asserted-by":"crossref","unstructured":"Odgren PR, Popoff SN, Safadi FF, et al. The toothless osteopetrotic rat has a normal vitamin D-binding protein-macrophage activating factor (DBP-MAF) cascade and chondrodysplasia resistant to treatments with colony stimulating factor-1 (CSF-1) and\/or DBP-MAF. Bone. 1999;25: 175-181.","DOI":"10.1016\/S8756-3282(99)00149-0"},{"key":"2019111712274099800_REF12","doi-asserted-by":"crossref","unstructured":"Yang M, Odgren PR. Molecular cloning and characterization of rat CCL9 (MIP-1gamma), the ortholog of mouse CCL9. Cytokine. 2005;31: 94-102.","DOI":"10.1016\/j.cyto.2005.04.001"},{"key":"2019111712274099800_REF13","doi-asserted-by":"crossref","unstructured":"Okamatsu Y, Kim D, Battaglino R, Sasaki H, Spate U, Stashenko P. MIP-1 gamma promotes receptor-activator-of-NF-kappa-B-ligand-induced osteoclast formation and survival. J Immunol. 2004;173: 2084-2090.","DOI":"10.4049\/jimmunol.173.3.2084"},{"key":"2019111712274099800_REF14","doi-asserted-by":"crossref","unstructured":"Lean JM, Murphy C, Fuller K, Chambers TJ. CCL9\/MIP-1gamma and its receptor CCR1 are the major chemokine ligand\/receptor species expressed by osteoclasts. J Cell Biochem. 2002;87: 386-393.","DOI":"10.1002\/jcb.10319"},{"key":"2019111712274099800_REF15","doi-asserted-by":"crossref","unstructured":"Yu X, Huang Y, Collin-Osdoby P, Osdoby P. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J Bone Miner Res. 2003;18: 1404-1418.","DOI":"10.1359\/jbmr.2003.18.8.1404"},{"key":"2019111712274099800_REF16","doi-asserted-by":"crossref","unstructured":"Yu X, Collin-Osdoby P, Osdoby P. SDF-1 increases recruitment of osteoclast precursors by upregulation of matrix metalloproteinase-9 activity. Connect Tissue Res. 2003;44: 79-84.","DOI":"10.1080\/03008200390152133"},{"key":"2019111712274099800_REF17","doi-asserted-by":"crossref","unstructured":"Yu X, Huang Y, Collin-Osdoby P, Osdoby P. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. J Bone Miner Res. 2004;19: 2065-2077.","DOI":"10.1359\/jbmr.040910"},{"key":"2019111712274099800_REF18","doi-asserted-by":"crossref","unstructured":"Oyajobi BO, Franchin G, Williams PJ, et al. Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease. Blood. 2003;102: 311-319.","DOI":"10.1182\/blood-2002-12-3905"},{"key":"2019111712274099800_REF19","doi-asserted-by":"crossref","unstructured":"Warme BA, Epstein NJ, Trindade MC, et al. Proinflammatory mediator expression in a novel murine model of titanium-particle-induced intramedullary inflammation. J Biomed Mater Res B Appl Biomater. 2004;71: 360-366.","DOI":"10.1002\/jbm.b.30120"},{"key":"2019111712274099800_REF20","doi-asserted-by":"crossref","unstructured":"Moser B, Wolf M, Walz A, Loetscher P. Chemokines: multiple levels of leukocyte migration control. Trends Immunol. 2004;25: 75-84.","DOI":"10.1016\/j.it.2003.12.005"},{"key":"2019111712274099800_","doi-asserted-by":"crossref","unstructured":"Ono SJ, Nakamura T, Miyazaki D, Ohbayashi M, Dawson M, Toda M. Chemokines: roles in leukocyte development, trafficking, and effector function. J Allergy Clin Immunol. 2003;111: 1185-1199.","DOI":"10.1067\/mai.2003.1594"},{"key":"2019111712274099800_REF22","doi-asserted-by":"crossref","unstructured":"Tran PB, Miller RJ. Chemokine receptors: signposts to brain development and disease. Nat Rev Neurosci. 2003;4: 444-455.","DOI":"10.1038\/nrn1116"},{"key":"2019111712274099800_REF23","doi-asserted-by":"crossref","unstructured":"Lindunger A, MacKay CA, Ek-Rylander B, Andersson G, Marks SC Jr. Histochemistry and biochemistry of tartrate-resistant acid phosphatase (TRAP) and tartrate-resistant acid adenosine triphosphatase (TrATPase) in bone, bone marrow and spleen: implications for osteoclast ontogeny. Bone Miner. 1990;10: 109-119.","DOI":"10.1016\/0169-6009(90)90086-U"},{"key":"2019111712274099800_REF24","doi-asserted-by":"crossref","unstructured":"Odgren PR, Kim N, MacKay CA, Mason-Savas A, Choi Y, Marks SC Jr. The role of RANKL (TRANCE\/TNFSF11), a tumor necrosis factor family member, in skeletal development: effects of gene knockout and transgenic rescue. Connect Tissue Res. 2003;44: 264-271.","DOI":"10.1080\/03008200390181753"},{"key":"2019111712274099800_REF25","doi-asserted-by":"crossref","unstructured":"Wani MR, Fuller K, Kim NS, Choi Y, Chambers T. Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. Endocrinology. 1999;140: 1927-1935.","DOI":"10.1210\/endo.140.4.6647"},{"key":"2019111712274099800_REF26","doi-asserted-by":"crossref","unstructured":"Marks SC, Jr., Lundmark C, Wurtz T, et al. Facial development and type III collagen RNA expression: concurrent repression in the osteopetrotic (Toothless, tl) rat and rescue after treatment with colony-stimulating factor-1. Dev Dyn. 1999;215: 117-125.","DOI":"10.1002\/(SICI)1097-0177(199906)215:2<117::AID-DVDY4>3.0.CO;2-D"},{"key":"2019111712274099800_REF27","unstructured":"Odgren PR, Gartland A, MacKay CA. Production of high-activity digoxigenin-labeled riboprobes for in situ hybridization using the AmpliScribe\u2122 T7 High Yield Transcription Kit. Epicentre Forum. 2003;10:6-7. Available online at http:\/\/www.epicentre.com\/pdfforum\/10_1ampliscribe.pdf."},{"key":"2019111712274099800_REF28","doi-asserted-by":"crossref","unstructured":"Horton JE, Harper J, Harper E. Platelet factor 4 regulates osteoclastic bone resorption in vitro. Biochim Biophys Acta. 1980;630: 459-462.","DOI":"10.1016\/0304-4165(80)90295-0"},{"key":"2019111712274099800_REF29","doi-asserted-by":"crossref","unstructured":"Scheuerer B, Ernst M, Durrbaum-Landmann I, et al. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood. 2000;95: 1158-1166.","DOI":"10.1182\/blood.V95.4.1158.004k31_1158_1166"},{"key":"2019111712274099800_REF30","doi-asserted-by":"crossref","unstructured":"Strieter RM, Polverini PJ, Arenberg DA, Kunkel SL. The role of CXC chemokines as regulators of angiogenesis. Shock. 1995;4: 155-160.","DOI":"10.1097\/00024382-199509000-00001"},{"key":"2019111712274099800_REF31","doi-asserted-by":"crossref","unstructured":"Lazzeri E, Romagnani P. CXCR3-binding chemokines: novel multifunctional therapeutic targets. Curr Drug Targets Immune Endocr Metabol Disord. 2005;5: 109-118.","DOI":"10.2174\/1568008053174723"},{"key":"2019111712274099800_REF32","doi-asserted-by":"crossref","unstructured":"Scheven BA, Milne JS, Hunter I, Robins SP. Macrophage-inflammatory protein-1alpha regulates preosteoclast differentiation in vitro. Biochem Biophys Res Commun. 1999;254: 773-778.","DOI":"10.1006\/bbrc.1998.9909"},{"key":"2019111712274099800_REF33","doi-asserted-by":"crossref","unstructured":"Khan IA, Murphy PM, Casciotti L, et al. Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection. J Immunol. 2001;166: 1930-1937.","DOI":"10.4049\/jimmunol.166.3.1930"},{"key":"2019111712274099800_","doi-asserted-by":"crossref","unstructured":"Broxmeyer HE, Cooper S, Hangoc G, Gao JL, Murphy PM. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1. J Exp Med. 1999;189: 1987-1992.","DOI":"10.1084\/jem.189.12.1987"},{"key":"2019111712274099800_REF35","doi-asserted-by":"crossref","unstructured":"Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF. The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol. 2000;165: 2677-2682.","DOI":"10.4049\/jimmunol.165.5.2677"},{"key":"2019111712274099800_REF36","doi-asserted-by":"crossref","unstructured":"Grassi F, Piacentini A, Cristino S, et al. Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12. Histochem Cell Biol. 2003;120: 391-400.","DOI":"10.1007\/s00418-003-0587-3"},{"key":"2019111712274099800_REF37","doi-asserted-by":"crossref","unstructured":"Grassi F, Cristino S, Toneguzzi S, Piacentini A, Facchini A, Lisignoli G. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. J Cell Physiol. 2004;199: 244-251.","DOI":"10.1002\/jcp.10445"},{"key":"2019111712274099800_REF38","doi-asserted-by":"crossref","unstructured":"Bendre MS, Montague DC, Peery T, Akel NS, Gaddy D, Suva LJ. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. Bone. 2003;33: 28-37.","DOI":"10.1016\/S8756-3282(03)00086-3"},{"key":"2019111712274099800_REF39","doi-asserted-by":"crossref","unstructured":"Votta BJ, White JR, Dodds RA, et al. CKbeta-8 [CCL23], a novel CC chemokine, is chemotactic for human osteoclast precursors and is expressed in bone tissues. J Cell Physiol. 2000;183: 196-207.","DOI":"10.1002\/(SICI)1097-4652(200005)183:2<196::AID-JCP6>3.0.CO;2-8"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/6\/2262\/1286366\/zh800606002262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/107\/6\/2262\/1286366\/zh800606002262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T15:23:44Z","timestamp":1683300224000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/107\/6\/2262\/22077\/Chemokine-and-chemokine-receptor-expression-during"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,15]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,3,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-08-3365","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,15]]}}}